Allotex Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Allotex General Information

Description

Operator of a biotechnology and medical device company intended to develop tissue-based solutions for refractive vision correction. The company develops precision-shaped human corneal collagen allograft implants for additive corneal procedures to treat presbyopia and other refractive disorders, enabling ophthalmic surgeons to restore vision through minimally invasive, tissue-based treatments.

Contact Information

Website
www.allotex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 27-43 Wormwood Street
  • Suite 160
  • Boston, MA 02210
  • United States
+1 (617)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 27-43 Wormwood Street
  • Suite 160
  • Boston, MA 02210
  • United States
+1 (617)

Allotex Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allotex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jan-2025 Completed Pre-Clinical Trials
2. Later Stage VC (Series B) 07-Jul-2023 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 02-Mar-2018 $16.7M $16.7M Completed Pre-Clinical Trials
To view Allotex’s complete valuation and funding history, request access »

Allotex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Allotex’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Allotex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology and medical device company intended to develop tissue-based solutions for refractive vision
Biotechnology
Boston, MA
30 As of 2026

Rockville, MD
 

Alpharetta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allotex Competitors (23)

One of Allotex’s 23 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenxbio Formerly VC-backed Rockville, MD
Clearside Biomedical Formerly VC-backed Alpharetta, GA
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
Nicox Formerly PE-Backed Biot, France
Claris Bio Venture Capital-Backed Half Moon Bay, CA
You’re viewing 5 of 23 competitors. Get the full list »

Allotex Patents

Allotex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3941395-A1 Corneal treatment Pending 18-Mar-2019
EP-3941395-A4 Corneal treatment Pending 18-Mar-2019
US-12605792-B2 Corneal treatment Active 18-Mar-2019
US-20220161370-A1 Corneal treatment Active 18-Mar-2019
US-20260316189-A1 Corneal treatment Pending 18-Mar-2019 B23K26/402
To view Allotex’s complete patent history, request access »

Allotex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allotex Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
One Six 8 Ventures Venture Capital Minority
Plaisance Capital Management Venture Capital Minority
Exor PE/Buyout Minority
Junson Capital Asset Manager Minority
KCK MedTech Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Allotex FAQs

  • When was Allotex founded?

    Allotex was founded in 2014.

  • Where is Allotex headquartered?

    Allotex is headquartered in Boston, MA.

  • What is the size of Allotex?

    Allotex has 30 total employees.

  • What industry is Allotex in?

    Allotex’s primary industry is Biotechnology.

  • Is Allotex a private or public company?

    Allotex is a Private company.

  • What is Allotex’s current revenue?

    The current revenue for Allotex is .

  • How much funding has Allotex raised over time?

    Allotex has raised $46.7M.

  • Who are Allotex’s investors?

    One Six 8 Ventures, Plaisance Capital Management, Exor, Junson Capital, and KCK MedTech are 5 of 7 investors who have invested in Allotex.

  • Who are Allotex’s competitors?

    Regenxbio, Clearside Biomedical, Adverum Biotechnologies, Nicox, and Claris Bio are some of the 23 competitors of Allotex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process